Mirtazapine - CISMeF

Preferred Label : Mirtazapine;

MeSH definition : A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.;

MeSH synonym : 6-Azamianserin; 6 Azamianserin;

MeSH hyponym : ORG-3770; ORG3770; Norset; Remergil; Zispin; (S)-Mirtazapine;

MeSH Related Number : 4685R51V7M;

Wikipedia link : https://en.wikipedia.org/wiki/Mirtazapine;

UNII : A051Q2099Q;

Details

Origin ID

D000078785;

UMLS CUI

C0049506;

ATC code(s)
- mirtazapine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Adverse reaction caused by mirtazapine (disorder) [SNOMED CT concept]
- Mirtazapine (substance) [SNOMED CT concept]
- mirtazapine [Substance BNPC]
MeSH indexing information
- carbon radioisotopes [MeSH Descriptor]
Pharmacological action(s)
- adrenergic alpha-2 receptor antagonists [MeSH Descriptor]
- anti-anxiety agents [MeSH Descriptor]
- antidepressive agents [MeSH Descriptor]
- central nervous system depressants [MeSH Descriptor]
- histamine h1 antagonists [MeSH Descriptor]
- serotonin 5-HT2 receptor antagonists [MeSH Descriptor]
- serotonin 5-HT3 receptor antagonists [MeSH Descriptor]
Record concept(s)
- (N-methyl-11C)mirtazapine [MeSH concept]
- ORG 3770 [MeSH concept]
- Org 50081 [MeSH concept]
- esmirtazapine [MeSH concept]
- mirtazapine [MeSH concept]
- remeron [MeSH concept]
- rexer [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Validated automatic mappings to BTNT
- (S)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine [Substance BNPC]
- mirtazapine [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients